陽電子放射断層撮影（PET）用ラジオトレーサーの世界市場レポート 2025年

陽電子放射断層撮影（PET）用ラジオトレーサー市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.1％で36億3,000万米ドルに成長します。予測期間の成長は、アプリケーションの拡大、規制当局の承認、新興市場の成長、老人人口の増加、PETラジオスキャナーの採用拡大などに起因します。予測期間の主な動向には、マイクロペット技術の開発、ウェアラブル技術との統合、セラノスティクスの拡大、ナノラジオトレーサー、データセキュリティのためのブロックチェーンなどがあります。

予想される感染症の増加は、今後数年間の陽電子放射断層撮影（PET）用ラジオトレーサー市場の成長を促進すると予測されます。感染症は、細菌、ウイルス、真菌、寄生虫などの病原性微生物によって引き起こされる病気です。これらの疾患の蔓延を助長する要因としては、気候変動、都市化、世界化、抗生物質耐性、人間の行動の変化などが挙げられ、これらすべてが病原体の蔓延を促進しています。PET放射線トレーサーは、代謝活性と炎症を可視化することにより、感染症の管理において重要な役割を果たし、感染症の検出、治療反応の評価、感染症と非感染症の鑑別を助け、最終的には患者の予後改善につながります。例えば、2024年2月、英国の政府機関であるUK Health Security Agencyの報告によると、イングランドにおける結核患者数は2023年に10.7％増加し、2022年の4,380人と比較して4,850人が報告されました。したがって、感染症の蔓延がPET放射性トレーサー市場の需要を促進しています。

PET放射性トレーサー市場の主要企業は、がんの検出を改善し、患者の転帰を向上させるPETイメージング剤などの高度診断ソリューションの開発に注力しています。PETイメージング剤は、PETスキャン中に体内の生物学的プロセスを可視化・測定するために利用される放射性物質です。例えば、2023年3月、カナダの放射性医薬品会社であるIsoLogic Innovative Radiopharmaceuticalsは、転移性前立腺がんの検出を目的とした前立腺がんイメージング薬剤として、Ga-68 Gozetotide Preparation Kit（PSMA-11）としても知られるIlluccixをカナダで発売しました。このツールは、医師が転移性疾患を特定し、十分な情報に基づき患者の管理を決定する上で極めて重要です。転移が疑われ、初回確定療法を受ける患者、および血清前立腺特異抗原（PSA）値の上昇により再発が疑われる患者に適応されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界陽電子放射断層撮影（PET）用ラジオトレーサーPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の陽電子放射断層撮影（PET）用ラジオトレーサー市場：成長率分析
• 世界の陽電子放射断層撮影（PET）用ラジオトレーサー市場の実績：規模と成長, 2019-2024
• 世界の陽電子放射断層撮影（PET）用ラジオトレーサー市場の予測：規模と成長, 2024-2029, 2034F
• 世界陽電子放射断層撮影（PET）用ラジオトレーサー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の陽電子放射断層撮影（PET）用ラジオトレーサー市場放射性トレーサーの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• F-18（フルオロデオキシグルコース18）
• Ga-68（線維芽細胞活性化タンパク質阻害剤）
• その他の放射性トレーサーの種類
• 世界の陽電子放射断層撮影（PET）用ラジオトレーサー市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん
• 心臓病
• 胃腸
• 内分泌
• 神経疾患
• その他の用途
• 世界の陽電子放射断層撮影（PET）用ラジオトレーサー市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センター
• その他のエンドユーザー
• 世界の陽電子放射断層撮影（PET）用ラジオトレーサー市場F-18（フルオロデオキシグルコース18）のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• F-18 FDG（フルオロデオキシグルコース）
• F-18フルオロエチルチロシン（FET）
• F-18フロルベタピル（アミロイドPETイメージング）
• 世界の陽電子放射断層撮影（PET）用ラジオトレーサー市場Ga-68（線維芽細胞活性化タンパク質阻害剤）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• Ga-68ドタテート（神経内分泌腫瘍イメージング）
• Ga-68 PSMA（前立腺特異膜抗原イメージング）
• Ga-68 FAPI（線維芽細胞活性化タンパク質阻害イメージング）
• 世界の陽電子放射断層撮影（PET）用ラジオトレーサー市場、その他の放射性トレーサーの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• C-11（炭素11）
• N-13（窒素13）
• O-15（酸素15）
• Rb-82（ルビジウム-82）
• I-124（ヨウ素124）

第7章 地域別・国別分析

• 世界の陽電子放射断層撮影（PET）用ラジオトレーサー市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の陽電子放射断層撮影（PET）用ラジオトレーサー市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 陽電子放射断層撮影（PET）用ラジオトレーサー市場：競合情勢
• 陽電子放射断層撮影（PET）用ラジオトレーサー市場：企業プロファイル
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Philips Healthcare
• Bracco Imaging S.p.A.
• Neusoft Medical Systems Co. Ltd.
• Lantheus Holdings Inc.
• Jubilant Pharma Limited
• SOFIE Biosciences（SOFIE）
• Yantai Dongcheng Pharmaceutical Group Co. Ltd.
• Nordion Inc.
• RefleXion Medical Inc.
• Isologic Innovative Radiopharmaceuticals
• ABX Advanced Biochemical Compounds GmbH
• IBA Radiopharma Solutions S.A.
• IXICO PLC
• ImaginAb Inc.
• Radiomedix Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 陽電子放射断層撮影（PET）用ラジオトレーサー市場2029：新たな機会を提供する国
• 陽電子放射断層撮影（PET）用ラジオトレーサー市場2029：新たな機会を提供するセグメント
• 陽電子放射断層撮影（PET）用ラジオトレーサー市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A positron emission tomography (PET) radiotracer is a radioactive substance used in PET imaging. This radiotracer is administered to a patient via injection, where it binds to specific biological targets, enabling the PET scanner to visualize metabolic activity and diagnose conditions such as cancer or neurological disorders.

The primary types of PET radiotracers include F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), and others. F-18 (Fluorodeoxyglucose 18) radiotracers are radioactive glucose analogs utilized in PET imaging to evaluate metabolic activity in tissues, particularly for cancer detection. These radiotracers are applied across various medical fields, including oncology, cardiology, gastrointestinal disorders, endocrine issues, and neurology. They are used by end-users such as hospitals and diagnostic centers, among others.

The positron emission tomography (PET) radiotracer market research report is one of a series of new reports from The Business Research Company that provides positron emission tomography (PET) radiotracer market statistics, including the positron emission tomography (PET) radiotracer industry's global market size, regional shares, competitors with a positron emission tomography (PET) radiotracer market share, detailed positron emission tomography (PET) radiotracer market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (PET) radiotracer industry. This positron emission tomography (PET) radiotracer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The positron emission tomography (PET) radiotracer market size has grown strongly in recent years. It will grow from $2.35 billion in 2024 to $2.57 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the increasing prevalence of infectious diseases, increasing awareness and accessibility, the emergence of novel radiotracers, the rising prevalence of cancer, and the increasing focus on preventive medicine.

The positron emission tomography (PET) radiotracer market size is expected to see strong growth in the next few years. It will grow to $3.63 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to the expansion of applications, regulatory approvals, growth in emerging markets, growing geriatric population, and growing adoption of PET radio scanners. Major trends in the forecast period include the development of micro-pet technology, integration with wearable technology, expansion of theranostics, nano-radiotracers, and blockchain for data security.

The anticipated rise in infectious diseases is projected to drive the growth of the positron emission tomography (PET) radiotracer market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites. Factors contributing to the increased prevalence of these diseases include climate change, urbanization, globalization, antibiotic resistance, and shifts in human behavior, all of which facilitate the spread of pathogens. PET radiotracers play a crucial role in managing infectious diseases by visualizing metabolic activity and inflammation, which aids in the detection of infections, assessment of treatment responses, and differentiation between infectious and non-infectious conditions, ultimately leading to improved patient outcomes. For example, in February 2024, a report from the UK Health Security Agency, a government agency in the UK, indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Hence, the growing prevalence of infectious diseases is driving demand for the PET radiotracer market.

Leading companies in the PET radiotracer market are concentrating on developing advanced diagnostic solutions, such as PET imaging agents that improve cancer detection and enhance patient outcomes. A PET imaging agent is a radioactive substance utilized to visualize and measure biological processes in the body during PET scans. For instance, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a Canadian radiopharmaceutical firm, launched Illuccix, also known as the Ga-68 Gozetotide Preparation Kit (PSMA-11), in Canada as a prostate cancer imaging agent aimed at detecting metastatic prostate cancer. This tool is crucial for physicians in identifying metastatic disease and making informed patient management decisions. It is indicated for patients suspected of metastasis who are candidates for initial definitive therapy, as well as for those with suspected recurrence indicated by elevated serum prostate-specific antigen (PSA) levels.

In February 2023, Lantheus Holdings Inc., a U.S.-based developer of diagnostic products, acquired Cerveau Technologies for an undisclosed sum. This acquisition is intended to enhance Lantheus Holdings' imaging pipeline, particularly for Alzheimer's disease diagnostics, by integrating Cerveau's MK-6240, a second-generation PET imaging agent that targets tau tangles in the brain. Cerveau Technologies Inc. is a U.S.-based provider of information and technology specializing in PET radiotracers.

Major companies operating in the positron emission tomography (PET) radiotracer market are Cardinal Health Inc., AstraZeneca PLC, Eli Lilly and Company, Siemens Healthineers AG, GE Healthcare Technologies Inc., Philips Healthcare, Bracco Imaging S.p.A., Neusoft Medical Systems Co Ltd., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences (SOFIE), Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., RefleXion Medical Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., IXICO PLC, ImaginAb Inc., Radiomedix Inc.

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the positron emission tomography (PET) radiotracer marker report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The positron emission tomography (PET) radiotracer market consists of sales of FDG (fluorodeoxyglucose), f-dopa (fluorodopa), C-11 methionine, C-11 methionine, F-18 naf (sodium fluoride), and C-11 choline. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Positron Emission Tomography (PET) Radiotracer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on positron emission tomography (pet) radiotracer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for positron emission tomography (pet) radiotracer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The positron emission tomography (pet) radiotracer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18); Ga-68 (Fibroblast Activation Protein Inhibitor); Other Radiotracer Types
• 2) By Application: Cancer; Heart Disease; Gastrointestinal; Endocrine; Neurological Disorders; Other Applications
• 3) By End-User: Hospitals; Diagnostic Centers; Other End-Users
• Subsegments:
• 1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose); F-18 Fluoroethyltyrosine (FET); F-18 Florbetapir (Amyloid PET Imaging)
• 2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging); Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging); Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
• 3) By Other Radiotracer Types: C-11 (Carbon-11); N-13 (Nitrogen-13); O-15 (Oxygen-15); Rb-82 (Rubidium-82); I-124 (Iodine-124)
• Companies Mentioned: Cardinal Health Inc.; AstraZeneca PLC; Eli Lilly and Company; Siemens Healthineers AG; GE Healthcare Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Positron Emission Tomography (PET) Radiotracer Market Characteristics

3. Positron Emission Tomography (PET) Radiotracer Market Trends And Strategies

4. Positron Emission Tomography (PET) Radiotracer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Positron Emission Tomography (PET) Radiotracer Growth Analysis And Strategic Analysis Framework

• 5.1. Global Positron Emission Tomography (PET) Radiotracer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Positron Emission Tomography (PET) Radiotracer Market Growth Rate Analysis
• 5.4. Global Positron Emission Tomography (PET) Radiotracer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Positron Emission Tomography (PET) Radiotracer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Positron Emission Tomography (PET) Radiotracer Total Addressable Market (TAM)

6. Positron Emission Tomography (PET) Radiotracer Market Segmentation

• 6.1. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• F-18 (Fluorodeoxyglucose 18)
• Ga-68 (Fibroblast Activation Protein Inhibitor)
• Other Radiotracer Types
• 6.2. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Heart Disease
• Gastrointestinal
• Endocrine
• Neurological Disorders
• Other Applications
• 6.3. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Centers
• Other End-Users
• 6.4. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of F-18 (Fluorodeoxyglucose 18), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• F-18 FDG (Fluorodeoxyglucose)
• F-18 Fluoroethyltyrosine (FET)
• F-18 Florbetapir (Amyloid PET Imaging)
• 6.5. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Ga-68 (Fibroblast Activation Protein Inhibitor), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ga-68 Dotatate (Neuroendocrine Tumor Imaging)
• Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging)
• Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
• 6.6. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Other Radiotracer Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• C-11 (Carbon-11)
• N-13 (Nitrogen-13)
• O-15 (Oxygen-15)
• Rb-82 (Rubidium-82)
• I-124 (Iodine-124)

7. Positron Emission Tomography (PET) Radiotracer Market Regional And Country Analysis

• 7.1. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market

• 8.1. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Positron Emission Tomography (PET) Radiotracer Market

• 9.1. China Positron Emission Tomography (PET) Radiotracer Market Overview
• 9.2. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Positron Emission Tomography (PET) Radiotracer Market

• 10.1. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Positron Emission Tomography (PET) Radiotracer Market

• 11.1. Japan Positron Emission Tomography (PET) Radiotracer Market Overview
• 11.2. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Positron Emission Tomography (PET) Radiotracer Market

• 12.1. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Positron Emission Tomography (PET) Radiotracer Market

• 13.1. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Positron Emission Tomography (PET) Radiotracer Market

• 14.1. South Korea Positron Emission Tomography (PET) Radiotracer Market Overview
• 14.2. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Positron Emission Tomography (PET) Radiotracer Market

• 15.1. Western Europe Positron Emission Tomography (PET) Radiotracer Market Overview
• 15.2. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Positron Emission Tomography (PET) Radiotracer Market

• 16.1. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Positron Emission Tomography (PET) Radiotracer Market

• 17.1. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Positron Emission Tomography (PET) Radiotracer Market

• 18.1. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Positron Emission Tomography (PET) Radiotracer Market

• 19.1. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Positron Emission Tomography (PET) Radiotracer Market

• 20.1. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market

• 21.1. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market Overview
• 21.2. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Positron Emission Tomography (PET) Radiotracer Market

• 22.1. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Positron Emission Tomography (PET) Radiotracer Market

• 23.1. North America Positron Emission Tomography (PET) Radiotracer Market Overview
• 23.2. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Positron Emission Tomography (PET) Radiotracer Market

• 24.1. USA Positron Emission Tomography (PET) Radiotracer Market Overview
• 24.2. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Positron Emission Tomography (PET) Radiotracer Market

• 25.1. Canada Positron Emission Tomography (PET) Radiotracer Market Overview
• 25.2. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Positron Emission Tomography (PET) Radiotracer Market

• 26.1. South America Positron Emission Tomography (PET) Radiotracer Market Overview
• 26.2. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Positron Emission Tomography (PET) Radiotracer Market

• 27.1. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Positron Emission Tomography (PET) Radiotracer Market

• 28.1. Middle East Positron Emission Tomography (PET) Radiotracer Market Overview
• 28.2. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Positron Emission Tomography (PET) Radiotracer Market

• 29.1. Africa Positron Emission Tomography (PET) Radiotracer Market Overview
• 29.2. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape And Company Profiles

• 30.1. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape
• 30.2. Positron Emission Tomography (PET) Radiotracer Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Positron Emission Tomography (PET) Radiotracer Market Other Major And Innovative Companies

• 31.1. Philips Healthcare
• 31.2. Bracco Imaging S.p.A.
• 31.3. Neusoft Medical Systems Co. Ltd.
• 31.4. Lantheus Holdings Inc.
• 31.5. Jubilant Pharma Limited
• 31.6. SOFIE Biosciences (SOFIE)
• 31.7. Yantai Dongcheng Pharmaceutical Group Co. Ltd.
• 31.8. Nordion Inc.
• 31.9. RefleXion Medical Inc.
• 31.10. Isologic Innovative Radiopharmaceuticals
• 31.11. ABX Advanced Biochemical Compounds GmbH
• 31.12. IBA Radiopharma Solutions S.A.
• 31.13. IXICO PLC
• 31.14. ImaginAb Inc.
• 31.15. Radiomedix Inc.

32. Global Positron Emission Tomography (PET) Radiotracer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Radiotracer Market

34. Recent Developments In The Positron Emission Tomography (PET) Radiotracer Market

35. Positron Emission Tomography (PET) Radiotracer Market High Potential Countries, Segments and Strategies

• 35.1 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Positron Emission Tomography (PET) Radiotracer Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer